本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neumora Therapeutics, Inc.

0.8313
-0.1681-16.82%
盤後0.85990.0286+3.44%16:38 EDT
成交量:139.97萬
成交額:122.33萬
市值:1.56億
市盈率:-0.68
高:1.03
開:1.02
低:0.8300
收:0.9994
52周最高:3.65
52周最低:0.8300
股本:1.88億
流通股本:1.16億
量比:1.60
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-1.2237
每股收益(LYR):-1.4501
淨資產收益率:-187.11%
總資產收益率:-73.85%
市淨率:3.51
市盈率(LYR):-0.57

資料載入中...

2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/11/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities